Skip to main content

Table 6 Univariate and multivariate analysis of predictors of complete response following neoadjuvant chemotherapy in patients with locally advanced cervical cancer who underwent neoadjuvant chemotherapy and radical hysterectomy

From: Pretreatment glycemic control status is an independent prognostic factor for cervical cancer patients receiving neoadjuvant chemotherapy for locally advanced disease

 

Complete response

 

Univariate analysis

Multivariate analysis

 

OR

95% CI

P value

OR

95% CI

P value

Age (years)

1.01

0.99–1.04

0.286

   

Body mass index (kg/m2)

1.19

1.01–1.39

0.037

1.27

1.04–1.55

0.020

Serum creatinine (μmol/l)

0.97

0.95–0.99

0.001

0.99

0.97–1.02

0.573

Tumor stage (IIA2 vs. IB2)

1.60

1.12–2.30

0.010

0.99

0.73–1.35

0.956

Histology (non-squamous vs. squamous)

1.55

0.64–3.71

0.329

   

Tumor differentiation (G3 vs. G1–2)

0.91

0.45–1.84

0.784

   

Diabetes

 No

Reference

Reference

Reference

Reference

Reference

Reference

 HbA1c < 7%

0.05

0.02–0.14

<0.0001

0.06

0.02–0.17

<0.0001

 HbA1c ≥ 7%

0.04

0.02–0.10

<0.0001

0.04

0.02–0.11

<0.0001

 Hypertension (yes vs. no)

0.34

0.20–0.59

<0.0001

0.38

0.20–0.74

0.004

 Cardiovascular disease (yes vs. no)

0.84

0.35–2.04

0.700

   

 Metformin (yes vs. no)

0.64

0.34–1.22

0.174

   
  1. Abbreviation: CI confidence interval, HbA 1c hemoglobin A1c, OR odds ratio